Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61P - Specific therapeutic activity of chemical compounds or medicinal preparations › A61P 9 - Drugs for disorders of the cardiovascular system
Patents for A61P 9 - Drugs for disorders of the cardiovascular system (159,484)
06/2003
06/19/2003US20030114473 Anticancer agents
06/19/2003US20030114469 Combinations
06/19/2003US20030114468 Psychological disorders
06/19/2003US20030114462 Drug abruse, alcoholism; respiratory system disorders, cardiovascular disorders
06/19/2003US20030114460 Pharmaceutical conjugates with enhanced pharmacokinetic characteristics
06/19/2003US20030114456 Antiinflammatory agents, analgesics, antipyretics
06/19/2003US20030114449 Saccharin derivatives as orally active elastase inhibitors
06/19/2003US20030114434 Extended duration light activated cancer therapy
06/19/2003US20030114427 Remedies and/or preventives for nervous system disorders
06/19/2003US20030114424 Treatment of cerebrovascular disease
06/19/2003US20030114422 Thrombosis, brain disorders, cardiovascular disorders, Alzheimer's disease, Huntington diseases
06/19/2003US20030114420 Anticancer agents, autoimmunine diseases, congestive heart failure, skin disorders, antiinflammatory agents
06/19/2003US20030114418 Analgesics; antiinflammatory and arthritic agents; osteoarthritis; rheumatic diseases; gastrointestinal, nervous system, respiratory disorders; wound healing agents; vision defects; kits
06/19/2003US20030114416 Analgesics; antiinflammatory, -arthritic agents; vision defects; gastrointestinal and uorgenital disorders; wound healing agents; kits
06/19/2003US20030114382 Angiogenesis inhibition
06/19/2003US20030114376 Tissue-factor-pathway inhibitors for treating eye vision defects
06/19/2003US20030114367 Composition for the prevention and/or treatment of artherosclerosis
06/19/2003US20030113881 D-enzyme compositions and methods of their use
06/19/2003US20030113870 Polypeptides homologous to VEGF and BMP1
06/19/2003US20030113844 Delayed rectifier potassium channel subunit
06/19/2003US20030113840 25 human secreted proteins
06/19/2003US20030113803 Orphan receptor
06/19/2003US20030113789 Protease peptides; anticarcinogenic agents; neurotransmitters; antidiabetic agents
06/19/2003US20030113775 7118, a human arginine N-methyltransferase family member and uses therefor
06/19/2003US20030113772 DNA encoding human alpha 1 adrenergic receptors and uses thereof
06/19/2003US20030113771 DNA encoding human alpha 1 adrenergic receptors and uses thereof
06/19/2003US20030113763 Oligonucleotide compositions and their use to induce apoptosis
06/19/2003US20030113714 Binding peptides to polycrystalline semiconductors; detection of bacteriophages; high density magnetic storage; medical imaging; forensics; antitumor agents; anticarcinogenic agents
06/19/2003US20030113393 Complex mixtures exhibiting selective inhibition of cyclooxygenase-2
06/19/2003US20030113366 Reverse-micellar delivery system for controlled transportation and enhanced absorption of agents
06/19/2003US20030113361 Palatable arginine compounds and uses thereof for cardiovascular health
06/19/2003US20030113359 Prosthetic device placed on the outside surface of the vessel or graft which then elutes antiproliferatives from a matrix
06/19/2003US20030113333 A kit containing a binding protein and a carrier molecule, binds with a hapten moiety and binds with a target antigen; monoclonal antibodies and engineered antibodies
06/19/2003US20030113331 An antagonist specifically binds to a denatured collagens; antitumor agents, antimetastasis agents; monoclonal antibodies; drug screening for denatured collagen antagonists
06/19/2003US20030113321 Novel G-protein-coupled receptor protein and its DNA
06/19/2003US20030113303 Delivering a translocation stimulator to a target zone of the tissue, introducing human embryonic stem cells to the mammal for homing the human to the target zone of the tissue for effecting myogenesis at the target zone
06/19/2003US20030113262 Gpib-lipid bond construct and use thereof
06/19/2003CA2822045A1 Stabilization of hypoxia inducible factor (hif) alpha
06/19/2003CA2469858A1 Functionalized higher diamondoids
06/19/2003CA2469730A1 Novel methods for treatment of cardiac arrhythmia, synthesis, and methods of use
06/19/2003CA2469709A1 Substituted hydrazones as inhibitors of cyclooxygenase-2
06/19/2003CA2469622A1 Substituted hydroxyethylamines
06/19/2003CA2469596A1 Ureas of 2-aminobenzothiazoles as adenosine modulators
06/19/2003CA2469316A1 Pyrimidine-based compounds useful as gsk-3 inhibitors
06/19/2003CA2469143A1 The use of acyl salicylates as heat shock inducers
06/19/2003CA2468544A1 Vanilloid receptor ligands
06/19/2003CA2468202A1 Assays and implements for determining and modulating hsp90 binding activity
06/19/2003CA2468156A1 Azolopyrimidinone compounds and their use
06/19/2003CA2467689A1 Stabilization of hypoxia inducible factor (hif) alpha using inhibitors of hif prolyl hydroxylase
06/19/2003CA2467245A1 Prevention of flap necrosis in plastic surgery
06/19/2003CA2465759A1 Method for administering birb 796 bs
06/19/2003CA2461491A1 Methods of screening for antagonists of apm1/gzip
06/18/2003EP1319408A1 Remedies for heart failure
06/18/2003EP1319183A2 Methods and products related to low molecular weight heparin
06/18/2003EP1319070A2 Mammalian receptor genes and uses
06/18/2003EP1319066A2 Isolated human kinase proteins, nucleic acid molecules and uses thereof
06/18/2003EP1319025A2 Human antibodies against pseudomonas aeruginosa lps derived from transgenic xenomouse
06/18/2003EP1319008A2 Water soluble rapamycin esters
06/18/2003EP1319007A1 Fused heterocyclic succinimide compounds and analogs thereof, modulators of nuclear hormone receptor function
06/18/2003EP1319003A1 Xanthine phosphodiesterase v inhibitors
06/18/2003EP1319002A1 Alpha v integrin receptor antagonists
06/18/2003EP1319001A1 Pyrazolopyridines and pyrazolopyridazines as antidiabetics
06/18/2003EP1318997A1 Pyrazole compounds useful as protein kinase inhibitors
06/18/2003EP1318996A2 Substituted imidazoles as dual histamine h1 and h3 agonists or antagonists
06/18/2003EP1318994A2 Substituted imidazoles as dual histamine h1 and h3 agonists or antagonists
06/18/2003EP1318993A2 Substituted imidazoles as dual histamine h1 and h3 agonists or antagonists
06/18/2003EP1318992A1 Imidazole derivatives as raf kinase inhibitors
06/18/2003EP1318991A1 Benzoic acid derivatives and uses thereof
06/18/2003EP1318988A2 Ligands for monoamine receptors and transporters, and methods of use thereof (neurotransmission)
06/18/2003EP1318985A2 4-amino-quinazolines
06/18/2003EP1318984A1 4-amino-quinazolines
06/18/2003EP1318983A2 Substituted imidazoles as dual histamine h1 and h3 agonists or antagonists
06/18/2003EP1318981A2 Quinoline and quinazoline derivatives as ligands for the neuropeptide y receptor
06/18/2003EP1318979A1 Cyclopentane derivatives as therapeutic agents
06/18/2003EP1318978A2 N-acylsulfonamide apoptosis promoters
06/18/2003EP1318977A1 Substituted phenylcyclohexane carboxylic acid amides and the use thereof
06/18/2003EP1318976A2 Substituted aminopropoxyaryl derivatives useful as agonists for lxr
06/18/2003EP1318836A2 Treatment of hyperproliferative diseases
06/18/2003EP1318829A1 Angiogenic agents and their uses
06/18/2003EP1318828A1 Orally administered peptides to ameliorate atherosclerosis
06/18/2003EP1318827A1 Polymer-modified synthetic proteins
06/18/2003EP1318826A2 Use of buchu extracts for hypertension
06/18/2003EP1318820A2 Xenon as medicament
06/18/2003EP1318817A1 Use of arginine in the preparation of a medicament for the prevention and treatment of the side effects associated with the intravenous administration of pharmaceuticals
06/18/2003EP1318816A1 Corticosteroid formulation comprising less than 2.5 mg prednisolone for once daily administration
06/18/2003EP1318814A2 Triazole compounds useful as protein kinase inhibitors
06/18/2003EP1318811A1 Cyclopentyl modulators of chemokine receptor activity
06/18/2003EP1318809A1 Micronized torsemide
06/18/2003EP1255757B1 Amino acid derivatives and use thereof as nep, ace and ece inhibitors
06/18/2003EP1232247A4 Modulation of signal transduction
06/18/2003EP1075475B1 Heterocyclic carboxamide derivatives as inhibitors of nitric oxide production
06/18/2003EP1015451B1 Tetrahydro gamma-carbolines
06/18/2003EP1011709A4 Inhibition of apoptotis using prosaposin receptor agonists
06/18/2003EP0907631B1 Inorganic ion receptor-active compounds
06/18/2003EP0819125B1 Thienyl-, furyl-, pyrrolyl- and biphenylsulfonamides and derivatives thereof that modulate the activity of endothelin
06/18/2003EP0815859B1 Intimal thickening inhibitors
06/18/2003EP0700298B1 Therapeutic use of hemoglobin in the treatment of blood vessel blockage
06/18/2003EP0538404B1 Fibroblast growth factor receptors
06/18/2003CN1425016A Benzoxathiepino [3,4-b] pyridine derivatives, process for their preparation and their use as medicaments
06/18/2003CN1425010A Cyclic compound
1 ... 1000 1001 1002 1003 1004 1005 1006 1007 1008 1009 1010 1011 1012 1013 1014 1015 1016 1017 1018 1019 1020 ... 1595